
Genetics and gene therapy
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Search results
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Despite the knock-on effects of the pandemic, there’s been a lot going on this year in the world of research! Here are snapshots of a few stories that have appeared in the Research News section of our website in 2022.
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
Join the Retina UK Lottery for a weekly dose of good fortune and good deeds!
Join our upcoming webinar to find out how you can get involved and fundraise for Retina UK this year.
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
Tomasz Tomkiewicz is undertaking a PhD studentship funded by Retina UK and The Macular Society.
Flip pancakes for people living with inherited sight loss. Take on our Flipping Fantastic Fundraising Challenge and try to flip as many pancakes as possible whilst raising money for Retina UK!
Steve is a Paralympian who was diagnosed with retinitis pigmentosa (RP) in 2011.
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.